FDA
label_change
· 2025-10-22
FDA Approved: VISINE ALLERGY EYE RELIEF MULTI-ACTION — Supplemental Application (Kenvue Brands LLC)
Summary
FDA approved a supplemental application to update the labeling for VISINE ALLERGY EYE RELIEF MULTI-ACTION, a combination eye drop containing naphazoline hydroch…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for VISINE ALLERGY EYE RELIEF MULTI-ACTION (NAPHAZOLINE HYDROCHLORIDE AND PHENIRAMINE MALEATE)